Investigator-initiated Clinical Trial (Phase II) of Cancer Vaccine "Dainippon Sumitomo Phama(DSP)-7888" for Acute Myeloid Leukemia Patients.

Clinical trial NCT04747002 · UNKNOWN

Trial details

NCT number: NCT04747002
Sponsor: Osaka University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia in Remission

Start date: 2020-06-12
Primary completion: 2024-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.